A case of peritoneal malignant mesothelioma following radiation therapy for cervical cancer

  • Authors:
    • Mitsutake Yano
    • Yuji Ikeda
    • Tomomi Kato
    • Mika Sakaki
    • Sho Sato
    • Akira Yabuno
    • Eito Kozawa
    • Masanori Yasuda
  • View Affiliations

  • Published online on: December 6, 2017     https://doi.org/10.3892/mco.2017.1525
  • Pages: 302-305
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study presents a case of peritoneal malignant mesothelioma (PMM) following radiation therapy for cervical cancer. A 34‑year‑old Japanese woman, without asbestos exposure, was referred to the Department of Gynecologic Oncology, Saitama Medical University International Medical Center due to a cervical mass, and was diagnosed with cervical squamous cell carcinoma (SCC). The serum levels of tumor markers, including SCC antigen and cancer antigen 125 (CA125) were 229.0 ng/ml and 54.4 U/ml, respectively. The patient underwent concurrent chemoradiotherapy (CCRT), and a complete response was achieved. After 54 months, ascites was found at the rectouterine pouch, but peritoneal cytology suggested reactive mesothelial cell. After 62 months of CCRT, magnetic resonance imaging revealed masses in both the salpinges. The serum levels of SCC and CA125 were 0.9 ng/ml and 506.1 U/ml, respectively. Following this, left salpingectomy and peritoneal biopsy were performed laparoscopically. Histologic examination revealed atypical mesothelial cells with no continuity of background tubal epithelium. Immunohistochemistry showed positive staining for calretinin, thrombomodulin, mesothelin and glucose transporter 1. Based on these findings, the patient was diagnosed with PMM epithelioid type and underwent systemic chemotherapy; stable disease status has been obtained for 3 months. This case demonstrates the possibility of PMM occurrence within 10 years after radiotherapy, and indicates the importance of histological and immunohistochemical examination, particularly in cases of an atypical tumorigenesis pattern from the primary cancer.
View Figures
View References

Related Articles

Journal Cover

February-2018
Volume 8 Issue 2

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yano M, Ikeda Y, Kato T, Sakaki M, Sato S, Yabuno A, Kozawa E and Yasuda M: A case of peritoneal malignant mesothelioma following radiation therapy for cervical cancer. Mol Clin Oncol 8: 302-305, 2018
APA
Yano, M., Ikeda, Y., Kato, T., Sakaki, M., Sato, S., Yabuno, A. ... Yasuda, M. (2018). A case of peritoneal malignant mesothelioma following radiation therapy for cervical cancer. Molecular and Clinical Oncology, 8, 302-305. https://doi.org/10.3892/mco.2017.1525
MLA
Yano, M., Ikeda, Y., Kato, T., Sakaki, M., Sato, S., Yabuno, A., Kozawa, E., Yasuda, M."A case of peritoneal malignant mesothelioma following radiation therapy for cervical cancer". Molecular and Clinical Oncology 8.2 (2018): 302-305.
Chicago
Yano, M., Ikeda, Y., Kato, T., Sakaki, M., Sato, S., Yabuno, A., Kozawa, E., Yasuda, M."A case of peritoneal malignant mesothelioma following radiation therapy for cervical cancer". Molecular and Clinical Oncology 8, no. 2 (2018): 302-305. https://doi.org/10.3892/mco.2017.1525